rhodamine 6g has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huo, C; Jin, B; Li, X; Song, C; Sun, M; Sun, Y; Tao, L; Yang, K; Yu, S; Zhang, C; Zhang, Z | 1 |
| Jin, B; Li, X; Li, Y; Song, C; Sun, Y; Tao, L; Yang, K; Zhang, Z | 1 |
2 other study(ies) available for rhodamine 6g and Liver Neoplasms
| Article | Year |
|---|---|
Anti-CD155 and anti-CD112 monoclonal antibodies conjugated to a fluorescent mesoporous silica nanosensor encapsulating rhodamine 6G and fluorescein for sensitive detection of liver cancer cells.
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Fluorescein; Fluorescent Dyes; Humans; Liver Neoplasms; Mice; Nanoparticles; Nectins; Receptors, Virus; Rhodamines; Silicon Dioxide | 2016 |
A fluorescent and chemiluminescent difunctional mesoporous silica nanoparticle as a label for the ultrasensitive detection of cancer cells.
Topics: Cell Line, Tumor; Humans; Liver Neoplasms; Luminescent Agents; Luminescent Measurements; Microscopy, Fluorescence; Nanoparticles; Organometallic Compounds; Oxidation-Reduction; Porosity; Rhodamines; Silicon Dioxide | 2013 |